最新消息

從細胞到個體、從個人到群體、從人群到動物、從體內保健到生態環保,GMI免疫調節蛋白全面地提供了良性循環的基礎。

GMI免疫調節蛋白有高度的協同性、安全性及有效性,已具備新藥開發的資格。

GMI Certification
Use of immunomodulatory protein from Ganoderma in inhibiting fibrosis 2021-11-16

ABSTRACT:

The present invention provides a method of preventing or treating fibrosis in a subject , comprising administering an effective amount of an immunomodulatory protein derived from Ganoderma lucidum , Ganoderma lucidum , Ganoderma tsugae , Ganoderma microsporum or Ganoderma sinensis to the subject , thereby preventing or treating a fibrosis .

 

 

出處聯結:US11058746B2

聯絡我們
聯絡位置

222 新北市深坑區北深路三段270巷12號8樓之1

聯絡電話

+886-2-2662-0148